MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Can Fite Biopharma Ltd Company Profile (NASDAQ:CANF)

Consensus Ratings for Can Fite Biopharma Ltd (NASDAQ:CANF) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.20 (80.79% upside)

Analysts' Ratings History for Can Fite Biopharma Ltd (NASDAQ:CANF)
Show:
DateFirmActionRatingPrice TargetActions
5/3/2015HC WainwrightReiterated RatingBuy$3.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015HC WainwrightLower Price TargetBuy$7.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015Roth CapitalDowngradeBuy -> Neutral$20.00 -> $2.40View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Roth CapitalSet Price TargetBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2014Roth CapitalLower Price TargetBuy$28.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014HC WainwrightInitiated CoverageBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2013Roth CapitalBoost Price Target$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha